Davis-based Marrone Bio Innovations Inc., a provider of bio-based pest management and plant health products, says it has initiated production of its “flagship” bioinsecticide, at its recently acquired plant in Michigan.
The company is producing Grandevo at the 11,400-square-foot manufacturing facility in Bangor. Marrone acquired the facility on 11 acres in July for an undisclosed price.
“As we expect to continue delivering double-digit sales growth of our existing products and plan for new product introductions, this new manufacturing capability will allow faster scale up, make us much more responsive to surges in market demand and more effective in managing our production costs,” said Hector Absi, MBI’s senior vice president of commercial operations.
Ultimately, MBI expects to put $32 million into a phased revitalization/expansion of the building.
Call The Bee’s Mark Glover, (916) 321-1184.